{
    "id": 29054,
    "fullName": "MCL1 L267V",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "MCL1 L267V lies within the BH1 motif of the Mcl1 protein (UniProt.org). L267V displays resistance to MCL1 inhibitors through the inability to release PMAIP1 (NOXA) and BAK1 after treatment (Blood 2018 132:951), but has not been biochemically characterized and therefore, its effect on Mcl1 protein function is unknown (PubMed, Dec 2019).",
            "references": [
                {
                    "id": 13096,
                    "pubMedId": null,
                    "title": "Myeloma Patient-Derived MCL1 Point Mutations Can Influence MCL1-Inhibitor Function",
                    "url": "http://www.bloodjournal.org/content/132/Suppl_1/951?sso-checked=true"
                },
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4170,
        "geneSymbol": "MCL1",
        "terms": [
            "MCL1",
            "bcl2-L-3",
            "BCL2L3",
            "EAT",
            "Mcl-1",
            "MCL1-ES",
            "mcl1/EAT",
            "MCL1L",
            "MCL1S",
            "TM"
        ]
    },
    "variant": "L267V",
    "createDate": "12/04/2018",
    "updateDate": "12/16/2019",
    "referenceTranscriptCoordinates": {
        "id": 177767,
        "transcript": "NM_021960",
        "gDna": "chr1:g.150578381G>C",
        "cDna": "c.799C>G",
        "protein": "p.L267V",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15326,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, AZD5991 treatment of a transformed murine B-ALL cell line with Mcl1 L267V, identified in multiple myeloma patient samples, did not induce cell apoptosis (PMID: Blood 2018 132:951).",
            "molecularProfile": {
                "id": 30984,
                "profileName": "MCL1 L267V"
            },
            "therapy": {
                "id": 6425,
                "therapyName": "AZD5991",
                "synonyms": null
            },
            "indication": {
                "id": 9538,
                "name": "multiple myeloma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 13096,
                    "pubMedId": null,
                    "title": "Myeloma Patient-Derived MCL1 Point Mutations Can Influence MCL1-Inhibitor Function",
                    "url": "http://www.bloodjournal.org/content/132/Suppl_1/951?sso-checked=true"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 15325,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, S63845 treatment of a transformed murine B-ALL cell line with Mcl1 L267V, identified in multiple myeloma patient samples, did not result in cell death (PMID: Blood 2018 132:951).",
            "molecularProfile": {
                "id": 30984,
                "profileName": "MCL1 L267V"
            },
            "therapy": {
                "id": 4858,
                "therapyName": "S63845",
                "synonyms": null
            },
            "indication": {
                "id": 9538,
                "name": "multiple myeloma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 13096,
                    "pubMedId": null,
                    "title": "Myeloma Patient-Derived MCL1 Point Mutations Can Influence MCL1-Inhibitor Function",
                    "url": "http://www.bloodjournal.org/content/132/Suppl_1/951?sso-checked=true"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 30984,
            "profileName": "MCL1 L267V",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 177767,
            "transcript": "NM_021960",
            "gDna": "chr1:g.150578381G>C",
            "cDna": "c.799C>G",
            "protein": "p.L267V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}